PET Imaging of Amyloid Plaque in Alzheimer's Disease: Insights into Pathogenesis of Disease

• University City Science Center

Brain amyloid plaques are a defining pathological lesion of Alzheimer's disease. However, until recently amyloid patholoy could not be measured in vivo, thus complicating efforts to elucidate the role of amyloid in pathogenesis of disease. Thus we have sough to develop a molecular imaging agent for PET imaging of amyloid plaques. Several clinical trials with such a compound, Florbetapir F18, have now been completed, and implications for our understanding of Alzheimer's pathogenesis will be discussed.

Speaker: Daniel Skovronsky, MD, PhD - Avid Radiopharmaceuticals

Presented by Dr. Nicholas Kefalides

11:30-12:00 Lunch and Networking

12:00-1:00 Lecture and Q&A

Please RSVP by November 5th

Space is limited, so attendence is strictly by RSVP.